A detailed history of Invesco Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Invesco Ltd. holds 3,680,808 shares of LLY stock, worth $2.77 Billion. This represents 0.65% of its overall portfolio holdings.

Number of Shares
3,680,808
Previous 3,288,142 11.94%
Holding current value
$2.77 Billion
Previous $2.98 Billion 9.54%
% of portfolio
0.65%
Previous 0.65%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $303 Million - $377 Million
392,666 Added 11.94%
3,680,808 $3.26 Billion
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $101 Million - $126 Million
138,821 Added 4.41%
3,288,142 $2.98 Billion
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $48.6 Million - $65.1 Million
82,149 Added 2.68%
3,149,321 $2.45 Billion
Q4 2023

Feb 12, 2024

SELL
$525.19 - $619.13 $100 Million - $118 Million
-190,873 Reduced 5.86%
3,067,172 $1.79 Billion
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $303 Million - $418 Million
-697,608 Reduced 17.64%
3,258,045 $1.75 Billion
Q2 2023

Aug 11, 2023

SELL
$350.74 - $468.98 $25.8 Million - $34.5 Million
-73,484 Reduced 1.82%
3,955,653 $1.86 Billion
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $34.1 Million - $40 Million
-109,689 Reduced 2.65%
4,029,137 $1.38 Billion
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $231 Million - $269 Million
-717,500 Reduced 14.77%
4,138,826 $1.51 Billion
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $17.2 Million - $19.6 Million
57,969 Added 1.21%
4,856,326 $1.57 Billion
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $1.79 Million - $2.1 Million
6,419 Added 0.13%
4,798,357 $1.56 Billion
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $113 Million - $141 Million
-482,716 Reduced 9.15%
4,791,938 $1.37 Billion
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $54.5 Million - $67.6 Million
242,241 Added 4.81%
5,274,654 $1.46 Billion
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $157 Million - $193 Million
-707,723 Reduced 12.33%
5,032,413 $1.16 Billion
Q2 2021

Aug 17, 2021

SELL
$180.55 - $233.54 $60.6 Million - $78.4 Million
-335,617 Reduced 5.52%
5,740,136 $1.32 Billion
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $63.2 Million - $81.8 Million
-384,766 Reduced 5.96%
6,075,753 $1.14 Billion
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $249 Million - $329 Million
1,907,345 Added 41.89%
6,460,519 $1.09 Billion
Q3 2020

Nov 16, 2020

SELL
$146.22 - $169.13 $42.6 Million - $49.3 Million
-291,280 Reduced 6.01%
4,553,174 $674 Million
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $83.9 Million - $101 Million
-615,095 Reduced 11.27%
4,844,454 $795 Million
Q1 2020

May 15, 2020

BUY
$119.05 - $147.35 $37.8 Million - $46.8 Million
317,893 Added 6.18%
5,459,549 $757 Million
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $45.2 Million - $56 Million
422,989 Added 8.96%
5,141,656 $676 Million
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $36.7 Million - $39.9 Million
-343,361 Reduced 6.78%
4,718,667 $528 Million
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $34.7 Million - $40.5 Million
-312,967 Reduced 5.82%
5,062,028 $561 Million
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $148 Million - $174 Million
-1,328,740 Reduced 19.82%
5,374,995 $697 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $710 Million - $795 Million
6,703,735 New
6,703,735 $776 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.